The decision came after a study described how seriously ill Covid-19 patients who were treated with the drug were more likely to die

“The review will consider data collected so far in the Solidarity Trial and, in particular robust randomized available data, to adequately evaluate the potential benefits and harms from this drug,” … Read More

Loading

Follow by Email
Pinterest
LinkedIn
Share